Plant used | Metal precursor | Morphology | Cell line | Techniques used | IC50 value | Impact | References |
---|---|---|---|---|---|---|---|
Silver | |||||||
Tamarindus indica Fruit shell extract | Silver nitrate | Spherical 20–52 nm | MCF7 | MTT assay, Dual staining (Ao/EtBr), DCFH-DA staining, Rhodamine 123 staining | 20 µg/mL | More nuclear morphological changes significant induction in MMP level compared to control | [216] |
Buchanania axillaris leaves | Silver nitrate | Spherical 17–80 nm | MCF7 | MTT assay | 31 µg/mL | The percent inhibitions of cell growth were found to increase with the increasing concentrations of the nanoparticle | [217] |
Cyperus conglomeratus Root Extracts | Silver nitrate | Spherical 70–100 nm | MCF7 | MTT assay, Flow cytometry, rtPCR | 5 μg/mL | The IC50 concentration of synthesized Ag NPs after 24 h treatment of MCF-7 cells significantly reduced the mRNA levels of Bcl2, survivin, and YAP genes compared with control untreated MCF-7 cells | [213] |
Phoenix dactylifera root extract | Silver nitrate | Spherical 21.65–41.05 nm | MCF-7 | MMTT assay, AO/EtBr staining, Flow cytometry | 29.6 μg/mL | At S-phase, it was discovered that the cell cycle is arrested, significantly slowing down the rate of cell division | [218] |
Conocarpus Lancifolius fruits extract | Silver nitrate | Spherical 5–30 nm | MDA-MB-231 | MMTT assay, DCFH-DA staining, Hoechst blue staining, Rhodamine 123 | 16.8 μg/mL | Observed dose-dependent cytotoxicity against MDA-MB-231 cells through activation of reactive oxygen species (ROS) generation | [219] |
Gold | |||||||
Mentha Longifolia leaf extract | Chloroauric acid | Spherical 36.4 nm | MCF7 Hs578Bst Hs319.T UACC-3133 | MTT assay | MCF7: 274 μg/mL Hs 578Bst: 279 μg/mL Hs 319.T: 274 μg/mL UACC-3133: 201 μg/mL | The biosynthesized nanoparticles had effective antibreast cancer effects against MCF7, Hs 578Bst, Hs 319.T, UACC-3133 cell lines without any cytotoxicity activity against normal cell line i.e., HUVEC | [220] |
Tecoma capensis (L.) leaves extract | Gold tetrachloroaurate | Spherical 10–35 nm | MCF7 | MTT assay, DPPH assay | T. capensis extract: 23.3 µg/mL T. capensis Au NPs: 9.6 µg/mL | Both T. capensis Au NPs and T. capensis extract showed significant antioxidant activity with DPPH scavenging percentages of 70.73% for T. capensis Au NPs and 85.62% for T. capensis extract | [221] |
Copper oxide | |||||||
Prunus nepalensis Fruit | Copper sulfate | Crystalline 42.5 nm | MCF7 Human normal cell line: MCF10A | MTT assay, Quantitative RT-PCR | 158.5 µg/mL | RT-PCR results showed upregulation in p53, caspase-3, Bax, and caspase-9. Down regulation of mRNA expression recorded in Myc and Ras genes in MCF-7 cells | [222] |
Acalypha indica leaf extract | Copper sulfate | Spherical 26–30 nm | MCF7 | MTT assay | 56.16 µg/mL | Plant-mediated copper oxide NPs showed best anticancer activity | [223] |
Syzygium alternifolium stem bark | Copper sulfate pentahydrate | Spherical 5–13 nm | MDA-MB-231 | MTT assay | 50 µg/mL | From 10, 25, 50, and 100 µg/mL, the concentration of CuONPs increased | [211] |
Wrightia tinctoria (Wt) extract | Copper sulfate pentahydrate | Spherical 15–40 nm | MCF-7 | MTT assay | 119.23 μg/mL | The release of copper ions from the nanoparticles, which bind to the cell's DNA, is the primary cause of Cu NPs harmful effects on cancer cells. As a result, it damages DNA and induces cell death | [224] |
Titanium oxide | |||||||
Gloriosa superba rhizome extract | Titanium hydroxide | Spherical 20–100 nm | MCF7 Normal fibroblast mouse cells: L929 | MMTT assay, AO/EtBr and Hoechst staining, DCFH-DA staining, Rhodamine 123, Comet assay | MCF-7: 46.64 µg/mL L929: 61.81 µg/mL | COMET assay confirmed the DNA destruction in the nanotitania-treated cancer cells. The biomolecule-coated nanotitania catalysts could be used as potential and novel comp | [210] |
Zanthoxylum armatum leaf extract | Titanium tetra butoxide | Spherical 15–50 nm | murine 4T1 mammary carcinoma cells | RPMI-1640 assay, Flow cytometry, TBARS assay, Hemolysis assay | 4.11 µg/mL | Z. armatum-derived NPs are as efficient as doxorubicin toward breast carcinoma with no symptoms of cardio toxicity and alteration in the body weight making them safer than doxorubicin | [225] |